![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
DACLATASVIR (BMS-790052), AN NS5A REPLICATION COMPLEX INHIBITOR, IN COMBINATION WITH PEGINTERFERON ALPHA-2B AND RIBAVIRIN IN JAPANESE TREATMENT-NAIVE AND NONRESPONDER PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION
|
|
|
Reported by Jules Levin
22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), Taipei International Convention Center, February 16-19, 2012
SUZUKI F,1 CHAYAMA K,2 KAWAKAMI Y,2 TOYOTA J,3 KARINO Y,3 MOCHIDA S,4 NAGOSHI S,4 HAYASHI N,5 TAKEHARA T,6 KUMADA H,1 1TORANOMON HOSPITAL, TOKYO, JAPAN; 2HIROSHIMA UNIVERSITY, HIROSHIMA, JAPAN; 3SAPPORO-KOUSEI GENERAL HOSPITAL, SAPPORO, JAPAN; 4SAITAMA MEDICAL UNIVERSITY, SAITAMA, JAPAN; 5KANSAI-ROUSAI HOSPITAL, AMAGASAKI, JAPAN; 6OSAKA UNIVERSITY, OSAKA, JAPAN
![APSAL1.gif](../images/022411/022412-2/APSAL1.gif)
![APSAL2.gif](../images/022411/022412-2/APSAL2.gif)
![APSAL3.gif](../images/022411/022412-2/APSAL3.gif)
![APSAL4.gif](../images/022411/022412-2/APSAL4.gif)
![APSAL5.gif](../images/022411/022412-2/APSAL5.gif)
![APSAL6.gif](../images/022411/022412-2/APSAL6.gif)
![APSAL7.gif](../images/022411/022412-2/APSAL7.gif)
![APSAL8.gif](../images/022411/022412-2/APSAL8.gif)
![APSAL9.gif](../images/022411/022412-2/APSAL9.gif)
![APSAL10.gif](../images/022411/022412-2/APSAL10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|